| pubmed-article:20199367 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C0305062 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:20199367 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:20199367 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20199367 | pubmed:dateCreated | 2010-3-4 | lld:pubmed |
| pubmed-article:20199367 | pubmed:abstractText | Rituximab is used after kidney transplant to prevention or treat kidney-allograft rejection. However, the impact of rituximab on the ability of patients to respond to tetanus toxoid vaccination has not yet been studied. | lld:pubmed |
| pubmed-article:20199367 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20199367 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20199367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20199367 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20199367 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20199367 | pubmed:issn | 1304-0855 | lld:pubmed |
| pubmed-article:20199367 | pubmed:author | pubmed-author:AbbalMichelM | lld:pubmed |
| pubmed-article:20199367 | pubmed:author | pubmed-author:RostaingLione... | lld:pubmed |
| pubmed-article:20199367 | pubmed:author | pubmed-author:BlancherAntoi... | lld:pubmed |
| pubmed-article:20199367 | pubmed:author | pubmed-author:KamarNassimN | lld:pubmed |
| pubmed-article:20199367 | pubmed:author | pubmed-author:FortMaryliseM | lld:pubmed |
| pubmed-article:20199367 | pubmed:author | pubmed-author:Puissant-Lubr... | lld:pubmed |
| pubmed-article:20199367 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20199367 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:20199367 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20199367 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20199367 | pubmed:pagination | 19-28 | lld:pubmed |
| pubmed-article:20199367 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:meshHeading | pubmed-meshheading:20199367... | lld:pubmed |
| pubmed-article:20199367 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20199367 | pubmed:articleTitle | Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney-transplant patients. | lld:pubmed |
| pubmed-article:20199367 | pubmed:affiliation | Laboratoire d'Immunologie, CHU de Toulouse, Hopital Rangueil, France. | lld:pubmed |
| pubmed-article:20199367 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20199367 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:20199367 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
